Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
Clinical trial NCT04862962 · COMPLETED
Trial details
- NCT number
- NCT04862962
- Sponsor
- Laboratorios Silanes S.A. de C.V.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-01-15
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.